Page last updated: 2024-12-08

enkephalin, pen(2,5)-4-chloro-phe(4)-

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

enkephalin, Pen(2,5)-4-chloro-Phe(4)-: delta opioid receptor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID159564
CHEMBL ID143939
MeSH IDM0176981

Synonyms (19)

Synonym
enkephalin, pen(2,5)-4-chloro-phe(4)-
CHEMBL143939 ,
122507-47-5
bdbm50068133
(4s,7s,13s)-13-[(s)-2-amino-3-(4-hydroxy-phenyl)-propionylamino]-7-(4-chloro-benzyl)-3,3,14,14-tetramethyl-6,9,12-trioxo-1,2-dithia-5,8,11-triaza-cyclotetradecane-4-carboxylic acid
(4s,7s,13s)-13-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-7-[(4-chlorophenyl)methyl]-3,3,14,14-tetramethyl-6,9,12-trioxo-1,2-dithia-5,8,11-triazacyclotetradecane-4-carboxylic acid
d-valine, l-tyrosyl-3-mercapto-d-valylglycyl-4-chloro-l-phenylalanyl-3-mercapto-, cyclic (2-5)-disulfide
pcl-dpdpe
enkephalin, penicillamine(2,5)-4-chlorophenylalanine(4)-
(d-pen2,5, pcl-phe4)enkephalin
(d-pen(2)-pcl-phe(4)-d-pen(5))enkephalin
2,5-penicillamine-4-(4-chlorophenylalanine)-enkephalin
dpdp(cl)e
enkephalin, d-pen(2), d-pen(5), p-cl-phe(4)
2,5-pen-4-(4-chloro-phe)-enkephalin
(d-pen2,5,p-cl-phe4)-enkephalin
DTXSID30153634
(d-pen2,p-chloro-phe4,d-pen5)-enkephalin
(4s,7s,13s)-13-((s)-2-amino-3-(4-hydroxyphenyl)propanamido)-7-(4-chlorobenzyl)-3,3,14,14-tetramethyl-6,9,12-trioxo-1,2-dithia-5,8,11-triazacyclotetradecane-4-carboxylic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (6)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Delta-type opioid receptorRattus norvegicus (Norway rat)IC50 (µMol)0.00160.00030.38877.0000AID149405
Mu-type opioid receptorRattus norvegicus (Norway rat)IC50 (µMol)0.60900.00010.887410.0000AID151300
Delta-type opioid receptorHomo sapiens (human)IC50 (µMol)0.00150.00020.75218.0140AID148085; AID148086
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)IC50 (µMol)0.00160.00030.71237.0700AID149405
Nociceptin receptorCavia porcellus (domestic guinea pig)Ki0.18000.00110.17650.6920AID268677
Mu-type opioid receptorCavia porcellus (domestic guinea pig)Ki0.18000.00000.27869.0000AID268677
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (19)

Processvia Protein(s)Taxonomy
immune responseDelta-type opioid receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayDelta-type opioid receptorHomo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerDelta-type opioid receptorHomo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathwayDelta-type opioid receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayDelta-type opioid receptorHomo sapiens (human)
adult locomotory behaviorDelta-type opioid receptorHomo sapiens (human)
negative regulation of gene expressionDelta-type opioid receptorHomo sapiens (human)
negative regulation of protein-containing complex assemblyDelta-type opioid receptorHomo sapiens (human)
positive regulation of CREB transcription factor activityDelta-type opioid receptorHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationDelta-type opioid receptorHomo sapiens (human)
response to nicotineDelta-type opioid receptorHomo sapiens (human)
G protein-coupled opioid receptor signaling pathwayDelta-type opioid receptorHomo sapiens (human)
eating behaviorDelta-type opioid receptorHomo sapiens (human)
regulation of mitochondrial membrane potentialDelta-type opioid receptorHomo sapiens (human)
regulation of calcium ion transportDelta-type opioid receptorHomo sapiens (human)
cellular response to growth factor stimulusDelta-type opioid receptorHomo sapiens (human)
cellular response to hypoxiaDelta-type opioid receptorHomo sapiens (human)
cellular response to toxic substanceDelta-type opioid receptorHomo sapiens (human)
neuropeptide signaling pathwayDelta-type opioid receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (5)

Processvia Protein(s)Taxonomy
G protein-coupled opioid receptor activityDelta-type opioid receptorHomo sapiens (human)
protein bindingDelta-type opioid receptorHomo sapiens (human)
receptor serine/threonine kinase bindingDelta-type opioid receptorHomo sapiens (human)
G protein-coupled enkephalin receptor activityDelta-type opioid receptorHomo sapiens (human)
neuropeptide bindingDelta-type opioid receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (9)

Processvia Protein(s)Taxonomy
plasma membraneDelta-type opioid receptorHomo sapiens (human)
synaptic vesicle membraneDelta-type opioid receptorHomo sapiens (human)
dendrite membraneDelta-type opioid receptorHomo sapiens (human)
presynaptic membraneDelta-type opioid receptorHomo sapiens (human)
axon terminusDelta-type opioid receptorHomo sapiens (human)
spine apparatusDelta-type opioid receptorHomo sapiens (human)
postsynaptic density membraneDelta-type opioid receptorHomo sapiens (human)
neuronal dense core vesicleDelta-type opioid receptorHomo sapiens (human)
plasma membraneDelta-type opioid receptorHomo sapiens (human)
neuron projectionDelta-type opioid receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID148085Binding affinity was measured against cloned human Opioid receptor delta 1 (wild-type,Wt)1998Journal of medicinal chemistry, Nov-19, Volume: 41, Issue:24
De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor.
AID268678Displacement of radiolabeled DPDPE-Cl from delta opioid receptor in Hartley guinea pig brain2006Bioorganic & medicinal chemistry letters, Aug-15, Volume: 16, Issue:16
Opiate receptor binding properties of morphine-, dihydromorphine-, and codeine 6-O-sulfate ester congeners.
AID268679Displacement of radiolabeled U69593 from kappa1 opioid receptor in Hartley guinea pig brain2006Bioorganic & medicinal chemistry letters, Aug-15, Volume: 16, Issue:16
Opiate receptor binding properties of morphine-, dihydromorphine-, and codeine 6-O-sulfate ester congeners.
AID149405Binding affinity was measured against Opioid receptor delta 1 using [3H]p-Cl-DPDPE as radioligand.1998Journal of medicinal chemistry, Nov-19, Volume: 41, Issue:24
De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor.
AID268680Displacement of radiolabeled NalBzOH from kappa3 opioid receptor in Hartley guinea pig brain2006Bioorganic & medicinal chemistry letters, Aug-15, Volume: 16, Issue:16
Opiate receptor binding properties of morphine-, dihydromorphine-, and codeine 6-O-sulfate ester congeners.
AID151300Binding affinity was measured against Opioid receptor mu 1 using [3H]-DAMGO as radioligand.1998Journal of medicinal chemistry, Nov-19, Volume: 41, Issue:24
De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor.
AID148086Binding affinity was measured against mutated human Opioid receptor delta 1 (W248L)1998Journal of medicinal chemistry, Nov-19, Volume: 41, Issue:24
De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor.
AID268677Displacement of radiolabeled DAMGO from mu opioid receptor in Hartley guinea pig brain2006Bioorganic & medicinal chemistry letters, Aug-15, Volume: 16, Issue:16
Opiate receptor binding properties of morphine-, dihydromorphine-, and codeine 6-O-sulfate ester congeners.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's8 (66.67)18.2507
2000's3 (25.00)29.6817
2010's1 (8.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.64 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.21 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]